RECRUITING

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and comittment therapy(ACT) + exercise + social support to address the substance (ab)use, violence, and AIDS/HIV (SAVA) to improve medication adherence for women living with HIV (WLWH). This intervention will be implemented by community based organizations that focus on WLWH across four counties. The main question it aims to answer are: * Will peer provision of ACT, exercise, and social support improve medication adherence for WLWH? * Will community based organizations be able to sustain the intervention after research is completed, and what changes will need to be made to sustain th eintervention.

Official Title

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

Quick Facts

Study Start:2024-09-19
Study Completion:2028-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06216600

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Is female sex at birth (cis-women)
  2. 2. Able to read and understand English
  3. 3. Able to participate in a low intensity exercise program
  4. 4. HIV-seropositive
  5. 5. At risk substance use (any illegal or unprescribed drug), tobacco, marijuana or alcohol use (four or more drinks in one day or 8 or more in one week).
  6. 6. Reports missing more ART doses than previous months, or \> 5 in a month, or has a detectable HIV viral load
  7. 7. Experienced interpersonal violence
  8. 8. Able and willing to provide informed consent
  9. 9. Confirmed COVID-19 vaccinated x 2 or willingness to wear a mask during inperson interactions.
  1. 1. Unwilling to participate in video record sessions (used to evaluate the quality of the intervention)
  2. 2. Enrolled in hospice
  3. 3. Not willing or not able to comply with study advisory board group participation agreement.

Contacts and Locations

Study Contact

Liliana Harkness
CONTACT
619-543-4753
lir003@health.ucsd.edu
Helene Le
CONTACT
619-543-3116
helenele@health.ucsd.edu

Principal Investigator

Maile Karris, MD
PRINCIPAL_INVESTIGATOR
UCSD

Study Locations (Sites)

UC San Diego AntiViral Research Center (AVRC)
San Diego, California, 92103
United States

Collaborators and Investigators

Sponsor: University of California, San Diego

  • Maile Karris, MD, PRINCIPAL_INVESTIGATOR, UCSD

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-19
Study Completion Date2028-05-31

Study Record Updates

Study Start Date2024-09-19
Study Completion Date2028-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • HIV Infections
  • Substance Use
  • Trauma
  • Medication Adherence